BCM
RMD icon

Buckhead Capital Management’s ResMed RMD Stock Holding History

Buckhead Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,327
Closed -$2.73M – 154
2025
Q4 		$2.73M Buy
11,327
+141
+1% +$36.1K 0.98% 43
2025
Q3 		$3.06M Buy
11,186
+640
+6% +$175K 1.11% 42
2025
Q2 		$2.72M Buy
+10,546
New +$2.52M 1.05% 38

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Buckhead Capital Management's RMD Position: Q1 2026 in Review

Buckhead Capital Management sold out of ResMed (RMD) in Q1 2026, closing a stake of 11,327 shares — an estimated $2.73M sold.

Buckhead Capital Management first reported a position in RMD in Q2 2025 and held it in 3 quarters. The position peaked at $3.06M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Buckhead Capital Management reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • Buckhead Capital Management sold 11,327 ResMed shares in Q1 2026, an estimated $2.73M.
  • Buckhead Capital Management first reported a position in ResMed in Q2 2025 and held it in 3 quarters.
  • Buckhead Capital Management's ResMed position peaked at $3.06M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Buckhead Capital Management's 13F filing for Q1 2026, filed 8 May 2026.